Creative Planning’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.74M | Buy |
9,199
+5,428
| +144% | +$949K | ﹤0.01% | 2010 |
|
|
2025
Q4 | $641K | Buy |
3,771
+105
| +3% | +$16.1K | ﹤0.01% | 2633 |
|
|
2025
Q3 | $483K | Buy |
3,666
+979
| +36% | +$117K | ﹤0.01% | 2756 |
|
|
2025
Q2 | $285K | Sell |
2,687
-3,999
| -60% | -$434K | ﹤0.01% | 2941 |
|
|
2025
Q1 | $830K | Buy |
6,686
+152
| +2% | +$19.8K | ﹤0.01% | 1866 |
|
|
2024
Q4 | $805K | Buy |
6,534
+2,782
| +74% | +$328K | ﹤0.01% | 1829 |
|
|
2024
Q3 | $418K | Sell |
3,752
-67
| -2% | -$7.34K | ﹤0.01% | 2264 |
|
|
2024
Q2 | $408K | Buy |
3,819
+680
| +22% | +$74.8K | ﹤0.01% | 2109 |
|
|
2024
Q1 | $378K | Buy |
3,139
+613
| +24% | +$75.1K | ﹤0.01% | 2061 |
|
|
2023
Q4 | $311K | Sell |
2,526
-298
| -11% | -$37.2K | ﹤0.01% | 2065 |
|
|
2023
Q3 | $366K | Buy |
2,824
+218
| +8% | +$29K | ﹤0.01% | 1778 |
|
|
2023
Q2 | $323K | Buy |
2,606
+1,104
| +74% | +$149K | ﹤0.01% | 1851 |
|
|
2023
Q1 | $220K | Sell |
1,502
-375
| -20% | -$55.5K | ﹤0.01% | 2053 |
|
|
2022
Q4 | $299K | Sell |
1,877
-572
| -23% | -$83.8K | ﹤0.01% | 1731 |
|
|
2022
Q3 | $326K | Buy |
2,449
+939
| +62% | +$143K | ﹤0.01% | 1599 |
|
|
2022
Q2 | $236K | Buy |
1,510
+1,469
| +3,583% | +$226K | ﹤0.01% | 1774 |
|
|
2022
Q1 | $6K | Buy |
+41
| New | +$5.95K | ﹤0.01% | 2231 |
|
|
2021
Q3 | – | Sell |
-1,323
| Closed | -$235K | – | 2168 |
|
|
2021
Q2 | $235K | Sell |
1,323
-199
| -13% | -$34.5K | ﹤0.01% | 1707 |
|
|
2021
Q1 | $250K | Buy |
1,522
+254
| +20% | +$41.8K | ﹤0.01% | 1913 |
|
|
2020
Q4 | $209K | Buy |
+1,268
| New | +$189K | ﹤0.01% | 1874 |
|
|
2018
Q4 | – | Sell |
-1,644
| Closed | -$276K | – | 2022 |
|
|
2018
Q3 | $276K | Buy |
1,644
+249
| +18% | +$42.8K | ﹤0.01% | 1457 |
|
|
2018
Q2 | $240K | Sell |
1,395
-244
| -15% | -$39.9K | ﹤0.01% | 1514 |
|
|
2018
Q1 | $247K | Buy |
+1,639
| New | +$240K | ﹤0.01% | 1470 |
|
|
2017
Q3 | – | Sell |
-1,336
| Closed | -$208K | – | 2815 |
|
|
2017
Q2 | $208K | Sell |
1,336
-194
| -13% | -$29.7K | ﹤0.01% | 1497 |
|
|
2017
Q1 | $222K | Sell |
1,530
-4,715
| -76% | -$614K | ﹤0.01% | 1427 |
|
|
2016
Q4 | $681K | Buy |
6,245
+4,065
| +186% | +$453K | ﹤0.01% | 788 |
|
|
2016
Q3 | $265K | Buy |
2,180
+337
| +18% | +$45.4K | ﹤0.01% | 1250 |
|
|
2016
Q2 | $260K | Hold |
1,843
| – | – | ﹤0.01% | 1121 |
|
|
2016
Q1 | $241K | Sell |
1,843
-47
| -2% | -$5.85K | ﹤0.01% | 1121 |
|
|
2015
Q4 | $266K | Sell |
1,890
-5,355
| -74% | -$742K | ﹤0.01% | 1053 |
|
|
2015
Q3 | $962K | Buy |
+7,245
| New | +$1.25M | 0.01% | 489 |
|
|
2015
Q2 | – | Sell |
-7,658
| Closed | -$1.32M | – | 2071 |
|
|
2015
Q1 | $1.32M | Sell |
7,658
-471
| -6% | -$80.8K | 0.01% | 379 |
|
|
2014
Q4 | $1.33M | Buy |
+8,129
| New | +$1.35M | 0.01% | 360 |
|
Other funds holding JAZZ
VPM
VCM
EC
Creative Planning's JAZZ Position: Q1 2026 in Review
Creative Planning increased its Jazz Pharmaceuticals (JAZZ) stake by 144% in Q1 2026, buying an estimated $949K and bringing the position to 9,199 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2010.
Creative Planning first reported a position in JAZZ in Q4 2014 and has held it in 33 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Creative Planning held 9,199 shares of Jazz Pharmaceuticals worth $1.74M as of Q1 2026.
- Creative Planning bought 5,428 Jazz Pharmaceuticals shares in Q1 2026, an estimated $949K.
- Jazz Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2010 holding.
- Creative Planning first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 33 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.